Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study

Haematologica

Volumn 84, Issue 8, 1999, Pages 726-729

  Lippi, Giuseppe ^a   Bassi, Antonella ^a   Brocco, Giorgio ^a   Manzato, Franco ^a   Marini, Maddalena ^a   Guidi, Giancesare ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b Lab Analisi Chimico Cliniche M   (Italy)

Author keywords

Atherosclerosis; Lipoprotein(a); Risk factor; Thrombosis; Venous thromboembolism

Indexed keywords

LIPOPROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; THROMBOEMBOLISM; THROMBOGENICITY; VEIN THROMBOSIS;

EID: 0032833742     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ascari E, Siragusa S, Piovella F. The epidemiology of deep vein thrombosis and pulmonary embolism. Haematologica 1995; 80(Suppl. 2):36-41.
2. Girolami A, Prandoni P, Simioni P, Girolami B, Scarano L, Zanon E. The pathogenesis of venous thromboembolism. Haematologica 1995; 80(2 Suppl):25-35.
3. Girolami A, Simioni P, Scarano L, Girolami B. Venous and arterial thrombophilia. Haematologica 1997; 82:96-100.
4. Lane D, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-62.
5. Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92:2353-8.
6. Laffan M, Tuddenham E. Assessing thrombotic risk. Br Med J 1998; 317:520-3.
7. De Moerloose P, Bounameux HR, Mannucci PM. Screening test for thrombophilic patients: which test, for which patient, by whom, when and why? Semin Thromb Haemost 1998; 24:321-7.
8. Harpel PC, Hermann A, Zhang X, Ostfeld I, Borth W. Lipoprotein(a), plasmin modulation, and atherogenesis. Thromb Haemost 1995; 74:382-6.
9. Marcovina SM, Levine DM, Lippi G. Lipoprotein(a): structure, measurement, and clinical significance. In: Rifai N, Warnick R, eds. Laboratory measurement of lipids, lipoproteins, and apolipoproteins. Washington, DC: AACC Press, 1994:253-64.
10. Nachman RL Thrombosis and atherogenesis: molecular connections. Blood 1992; 79:1897-906.
11. Tavola A, Viganò D'Angelo S, Bandello F, et al. Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein(a) levels: a case report. Thromb Res 1995; 80:327-31.
12. Berg K, Roald B, Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 1994; 46:52-6.
13. Lippi G, Veraldi GF, Dorucci V, et al. The usefulness of lipids, lipoprotein(a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery. Scand J Clin Lab Invest 1998; 58:1-8.
14. Császár A, Karadi I, Juhasz E, Romics L High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism. Eur J Clin Invest 1995; 25: 368-70.
15. Ignatescu M, Kostner K, Zorn G, et al. Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension. Thromb Haemost 1998; 80:231-2.
16. Atsumi T, Khamashta MA, Andujar C, et al. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol 1998; 25:69-73.
17. Orem A, Deger O, Memis O, Bahadir S, Ovali E, Cimsit G. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease. Ann Rheum Dis 1995; 54:726-9.
18. Seriolo B, Accardo S, Cutolo M. Lipoprotein(a) and other risk factors for thrombosis in rheumatoid arthritis. J Rheumatol 1996; 23:194-6.
19. LeBlanc K, Samuelsson J. Elevated plasma lipoprotein(a). A potential risk factor for thromboembolic complications in polycythaemia vera. EurJ Haematol 1996; 57:257-8.
20. Murata M, Saito T, Takahashi S, Ichinose A. Plasma lipoprotein(a) levels are high in patients with central retinal artery occlusion. Thromb Res 1998; 91:169-75.
21. Marz W, Trommlitz M, Scharrer I, Gross W. Apolipoprotein (a) concentrations are not related to the risk of venous thrombosis. Blood Coagul Fibrinolysis 1991; 2:595-9.
22. Nowak-Göttl U, Debus O, Findeisen M, et al. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics 1997; 99:E11.
23. Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997; 78:1-6.
24. Carmeliet P, Collen D. Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis. Curr Opin Lipidol 1997; 8:118-25.
25. Hoff EF, O'Neil J, Yashiro A. Partial characterization of lipoproteins containing apo(a) in human atherosclerotic lesions. J Lipid Res 1993; 34:789-98.